Cerebral Amyloidosis in Individuals with Subjective Cognitive Decline: From Genetic Predisposition to Actual Cerebrospinal Fluid Measurements

Sampatakakis, S. N., Mourtzi, N., Charisis, S., Kalligerou, F., Mamalaki, E., Ntanasi, E., Hatzimanolis, A., Koutsis, G., Ramirez, A., Lambert, J.-C., Yannakoulia, M., Kosmidis, M. H., Dardiotis, E., Hadjigeorgiou, G., Sakka, P., Rouskas, K., Patas, K., & Scarmeas, N. (2024). Cerebral Amyloidosis in Individuals with Subjective Cognitive Decline: From Genetic Predisposition to Actual Cerebrospinal Fluid Measurements. Biomedicines, 12(5), 1053. https://doi.org/10.3390/biomedicines12051053
Authors:
Stefanos N. Sampatakakis
Niki Mourtzi
Sokratis Charisis
Faidra Kalligerou
Eirini Mamalaki
Eva Ntanasi
Alex Hatzimanolis
Georgios Koutsis
Alfredo Ramirez
Jean-Charles Lambert
Mary Yannakoulia
Mary H. Kosmidis
Efthimios Dardiotis
Georgios Hadjigeorgiou
Paraskevi Sakka
Konstantinos Rouskas
Kostas Patas
Nikolaos Scarmeas
Affiliated Authors:
Nikolaos Scarmeas
Author Keywords:
subjective cognitive decline
genetics
alzheimer's disease
biomarkers
alzheimer’s disease
Publication Type:
Article
Unique ID:
10.3390/biomedicines12051053
Journal:
Publication Date:
Data Source:
Scopus

Record Created: